Last Posted: Aug 06, 2018
- Genomic biomarkers in prostate cancer.
Kornberg Zachary et al. Translational andrology and urology 2018 Jun (3) 459-471 - Liquid biopsy approach in the management of prostate cancer.
Riaz Irbaz Bin et al. Translational research : the journal of laboratory and clinical medicine 2018 May - Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional
HIH funding announcement, August 2018 - A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Degener Stephan et al. Mini reviews in medicinal chemistry 2018 18(13) 1133-1142 - A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
Vos Shoko et al. Critical reviews in oncology/hematology 2018 Jul 12729-41 - Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
Schwartzberg Barbara S et al. American journal of surgery 2018 Jul - Blood based biomarkers beyond genomics for lung cancer screening.
Hanash Samir M et al. Translational lung cancer research 2018 Jun 7(3) 327-335 - BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
Kowalik Artur et al. PloS one 2018 13(7) e0201086 - Coping Mechanisms, Psychological Distress, and Quality of Life Prior to Cancer Genetic Counseling.
Di Mattei Valentina E et al. Frontiers in psychology 2018 91218 - Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.
Peluso Gaia et al. BioMed research international 2017 20172605628
.png)
No hay comentarios:
Publicar un comentario